Use of PRO measures to inform tolerability in oncology trials: Implications for clinical review, IND safety reporting and clinical site inspections
| Image |  |
|---|---|
| Description | scientific article published on 13 December 2017 |
| Author/s |
author: Sandra A Mitchell Susan E. Mullally Richard L Piekarz |
| Publication date | December 13, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |